The risk of autism spectrum disorder (ASD) in children was higher in mothers with type 1 diabetes (T1D), a recent study found.
The risk of autism spectrum disorder (ASD) in children was higher in mothers with type 1 diabetes (T1D) diagnosed by 26 weeks’ gestation, according to a new research letter in JAMA.
The risk of ASD in offspring of mothers with type 2 diabetes (T2D) and gestational diabetes mellitus (GDM) diagnosed by 26 weeks’ gestation was also higher, although that association was known previously, the researchers said. However, GDM diagnosed after 26 weeks’ gestation was not associated with an increased risk.
The researchers said the results suggest that the severity of maternal diabetes and the timing of exposure—early versus late in pregnancy—may be a factor.
This retrospective study using electronic health records included singleton children born at 28 to 44 weeks’ gestation in Kaiser Permanente Southern California (KPSC) hospitals from January 1, 1995, through December 31, 2012. Children were tracked through from age 1 until the first date of the following: clinical diagnosis of ASD, last date of continuous KPSC membership, death, or study end date of December 31, 2017.
Of the 419,425 children (boys, 51%) who met the study criteria, 621 were exposed to maternal T1D, 9453 to maternal T2D, 11,922 to GDM diagnosed by 26 weeks’ gestation, and 24,505 to GDM diagnosed after 26 weeks’ gestation.
During a median follow-up of 6.9 years (interquartile range, 3.4-11.9), 5827 children were diagnosed with ASD.
Unadjusted average annual ASD incidence rates per 1000 children were:
Relative to no diabetes exposure, the adjusted hazard ratios for exposure to maternal diabetes were 2.36 (95% CI, 1.36-4.12) for T1D; 1.45 (95% CI, 1.24-1.70) for T2D; 1.30 (95% CI, 1.12-1.51) for GDM by 26 weeks’ gestation; and 0.99 (95% CI, 0.88-1.12) for GDM after 26 weeks.
Confounding due to risk factors from the father and other intrauterine and postnatal exposures could not be assessed, the researchers said. Further areas for study include the potential role of maternal glycemia; other features of T1D, such as autoimmunity and genetic factors prematurity; and neonatal hypoglycemia.
Reference
Xiang AH, Wang X, Martinez MP, Page K, Buchanan TA, Feldman K. Maternal Type 1 diabetes and risk of autism in offspring. [published online June 23, 2018]. JAMA. doi:10.1001/jama.2018.7614
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Addressing Maternal Mortality in Medicaid by Focusing on Mental Health
February 15th 2023On this episode of Managed Care Cast, we speak with Inland Empire Health Plan, a managed care plan serving more than 1.4 million residents on Medi-Cal in California, about a new maternal mental health program aimed at supporting new mothers, both before they give birth and afterward.
Listen
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
For National Women’s Health Week, One Company Emphasizes Cardiovascular Risk Management
May 10th 2022On this episode of Managed Care Cast, we speak with Joanne Armstrong, MD, MPH, vice president and chief medical officer for Women’s Health and Genomics at CVS Health, on the distinct pathophysiology of cardiovascular disease in women and how her own health experiences have influenced her perspective on cardiovascular disease management.
Listen